Search

Your search keyword '"Yoshihara, Ai"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Yoshihara, Ai" Remove constraint Author: "Yoshihara, Ai" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
45 results on '"Yoshihara, Ai"'

Search Results

1. Effects of Levothyroxine Treatment on Fertility and Pregnancy Outcomes in Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

2. Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification

3. Adult Thyroid Outcomes of Congenital Hypothyroidism

4. Incidence of and Risk Factors for Neonatal Hypothyroidism among Women with Graves’ Disease Treated with Antithyroid Drugs until Delivery

5. Establishment of reference intervals for fT3, fT4, and TSH levels in Japanese children and adolescents

6. Radioiodine uptake after monotherapy with potassium iodide in patients with Graves’ disease

8. Prediction model of Graves’ disease in general clinical practice based on complete blood count and biochemistry profile

9. The Mediation Role of Thyrotropin Receptor Antibody in the Relationship Between Age and Severity of Hyperthyroidism in Graves' Disease

11. The Relationship Between Primary Thyroid Lymphoma and Various Types of Thyroid Autoimmunity: A Retrospective Cohort Study of 498 Cases, Including 9 Cases with Graves' Disease

12. Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic

13. Does Age or Sex Relate to Severity or Treatment Prognosis in Graves' Disease?

16. The Potential Impact of the COVID-19 Pandemic on Clinical Management of Thyroid Disorders in Japan

17. Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves’ Disease Develop?

18. Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution

19. A case of macro-TSH consisting of IgA-bound TSH

21. Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease

22. Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy

24. Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves’ disease

25. Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic.

26. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves’ Disease in Japan

27. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy

28. Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease

29. Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease

30. Seasonal Changes in Serum Thyrotropin Concentrations Observed from Big Data Obtained During Six Consecutive Years from 2010 to 2015 at a Single Hospital in Japan

31. Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease

33. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan

34. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves’ ophthalmopathy in untreated Japanese Graves’ disease patients

35. The characteristics of osteoporotic patients in Graves’ disease patients newly diagnosed after menopause: a prospective observational study

36. Levothyroxine supplementation improves serum anti‐Müllerian hormone levels in infertile patients with Hashimoto’s thyroiditis.

37. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan

39. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves’ disease and GTT?

40. Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves' disease.

41. Subacute thyroiditis during pregnancy: clinical characteristics of seven cases.

42. Exacerbation of Thyroid Eye Disease and Dysthyroid Optic Neuropathy During Pregnancy: A Case Report.

43. An Evaluation of the Efficacy of Machine Learning in Predicting Thyrotoxicosis and Hypothyroidism: A Comparative Assessment of Biochemical Test Parameters Used in Different Health Checkups.

44. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.

45. Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score.

Catalog

Books, media, physical & digital resources